Dados
Levantado até a data: $147,972
Compromissos agregados $
Total: $ '+ total_amount_formatted +'
'; retorno (pairar); }, resize: true, smooth: false, verticalGrid: true}); jQuery ('# analytics-tabs'). on ('change.zf.tabs', function (e) {if (jQuery ('# deal_basics: visible'). length) {totalChart.redraw (); jQuery (janela) .trigger ('resize');}}); });
Capital líquido
10/03/2019
04/28/2020
$10,000
$1,070,000
$4
Patrimônio líquido - comum
RegCF
Seed
$19,621,196
Compromissos rotativos $
Período anterior: $ '+ Weekly_amount_formatted +'
'; retorno (pairar); }, resize: true, smooth: false, verticalGrid: true}); jQuery ('# analytics-tabs'). on ('change.zf.tabs', function (e) {if (jQuery ('# investment_momentum: visible'). length) {WeeklyChart.redraw (); jQuery (janela) .trigger ('resize');}}); });
Financiado
05/03/2020
Financiado
1,480%
14%
Financiado
$711
Financiado
Localização
Saúde e produtos farmacêuticos
Biotecnologia
B2B
Alta
Alta
Alto crescimento
SelenBio, a biotechnology company with a post-money valuation of $20.7 million, is raising funds on NetCapital. The company develops an antibacterial technology that prevents the formation of biofilm in dental, medical, industrial, and consumer applications. SelenBio uses a unique selenium-based compound, SELDOX, to keep the applications infection-free. The company was founded by Kenny Gallagher and Karl Doenges. The proceeds of the current crowdfunding round, with a minimum target of $10,000 and a maximum target of $1,070,000, will be used for research & development, operations, completion of current projects, sales & marketing, and compensation for managers. SelenBio is working on multiple projects with excellent traction and has already received the FDA approval for SELDOX.
Declaração resumida de lucros e perdas
|
Receita |
$12,142 |
$1,039 |
|
CPV |
$11,785 |
$871 |
|
Imposto |
$0 |
$0 |
|
|
||
|
|
||
|
Lucro Líquido |
$ -453,939 |
$ -134,867 |
Folha de balanço resumida
|
dinheiro |
$550,794 |
$104,479 |
|
Contas a receber |
$153 |
$213 |
|
Total de ativos |
$1,044,713 |
$475,538 |
|
Dívida de curto prazo |
$0 |
$0 |
|
Dívida de longo prazo |
$0 |
$0 |
|
Total do Passivo |
$0 |
$0 |
Source: https://www.crowditz.com/2019/10/selenbio-on-netcapital/
